Exploring China's Business Frontiers: Resilience, Innovation, and Challenges Go back »
Click here to view pictures of this event.
-
Time2023-08-23 | 14:00 - 15:15
-
Venue:European Chamber Shanghai Office
-
Address:Unit 2204, 22nd Floor, Shui On Plaza, 333 Huai Hai Zhong Road, Shanghai
-
Fee:Members: 200 |
Non Members: 400
Download event materials
We kindly request that all attendees complete a quick feedback form before downloading.
| Bill_Russo_Automobility.pdf Attendees only |
Speakers
Mr. Ker Gibbs
Ker Gibbs (editor). Mr. Gibbs first came to China in 1985 and has worked in banking, consulting, and other roles giving him broad exposure to the issues that foreign companies face in Asia, as well as U.S.-China relations. He recently stepped down from his role as President of the American Chamber of Commerce in Shanghai.
Ms. Jean Liu
Jean Liu (co-author). Ms Liu is the Chief Corporate Affairs Officer with EF, Education First in China. She also worked in IT, telecommunications, advertising, and the public relations sector. Her career has included positions in government affairs, marketing, brand management, M&A, and business development. A Beijing native, Ms Liu has degrees from Wellesley College and the University of Chicago.
Mr. Bill Russo
Bill Russo (co-author). Mr. Russo is the Founder and CEO of Automobility, and the former regional head of Chrysler in North East Asia. He is a highly sought-after commentator and opinion leader on the development of the China market and the automotive industry. His 40 years of experience includes 15 years with Chrysler, and 20 years working in Asia. Mr. Russo has degrees from Columbia University and Lehigh.
Mr. Dan Brindle
Dan Brindle became President of Novartis Group (China) on September 1, 2020. He is responsible for developing and driving implementation of Novartis’ integrated strategy for China, including external engagement, business development and expanding market access for Novartis medicines in the country.
Mr. Brindle joined Novartis from the China law firm ZY Partners, where he was a partner focused on China corporate law and external strategic engagement. Prior to this role, he was Vice President, International Government Affairs for GlaxoSmithKline in Singapore. Mr. Brindle also held senior leadership roles with Pfizer and Eli Lilly & Company across Asia and in the United States.
Mr. Brindle has a long-standing connection with Asia, especially with China. He has completed extensive coursework in Asian studies, spent most of his career in Asia and held important roles in organizations including APEC and the US-ASEAN Business Council, facilitating relations between Asia and the West.
Mr. Brindle holds a law degree from Lewis & Clark Law School and is a Member of the State Bar of California. He earned his Bachelor of Arts degree in Asian studies from the University of Puget Sound, and conducted graduate coursework at Cornell University and at the Hopkins-Nanjing Center for Chinese & American Studies in China.
After joining Novartis, Mr. Brindle relocated to Shanghai with his family. He speaks English, Mandarin, Japanese and Spanish.